These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16988806)

  • 1. [Drug therapy for irritable bowel syndrome. What works, what doesn't work and for whom?].
    Mönnikes H; Schmidtmann M; van der Voort IR
    Internist (Berl); 2006 Oct; 47(10):1073-6, 1078-83. PubMed ID: 16988806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome.
    Frissora CL; Cash BD
    Aliment Pharmacol Ther; 2007 Jun; 25(11):1271-81. PubMed ID: 17509095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central Neuromodulators in Irritable Bowel Syndrome: Why, How, and When.
    Hanna-Jairala I; Drossman DA
    Am J Gastroenterol; 2024 Jul; 119(7):1272-1284. PubMed ID: 38595149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation.
    Chang L; Sultan S; Lembo A; Verne GN; Smalley W; Heidelbaugh JJ
    Gastroenterology; 2022 Jul; 163(1):118-136. PubMed ID: 35738724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
    Thomas RH; Luthin DR
    Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants for irritable bowel syndrome-A systematic review.
    Kułak-Bejda A; Bejda G; Waszkiewicz N
    Pharmacol Rep; 2017 Dec; 69(6):1366-1379. PubMed ID: 29132094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options in irritable bowel syndrome.
    Farthing MJ
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):773-86. PubMed ID: 15324713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea.
    Lembo A; Sultan S; Chang L; Heidelbaugh JJ; Smalley W; Verne GN
    Gastroenterology; 2022 Jul; 163(1):137-151. PubMed ID: 35738725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2008 Clinical approach to irritable bowel syndrome.
    Astegiano M; Pellicano R; Sguazzini C; Berrutti M; Simondi D; Reggiani S; Rizzetto M
    Minerva Gastroenterol Dietol; 2008 Sep; 54(3):251-7. PubMed ID: 18614974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.
    Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
    Am J Gastroenterol; 2014 Sep; 109(9):1350-65; quiz 1366. PubMed ID: 24935275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.
    Shah E; Kim S; Chong K; Lembo A; Pimentel M
    Am J Med; 2012 Apr; 125(4):381-93. PubMed ID: 22444104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in pharmacological treatment of irritable bowel syndrome.
    Lazaraki G; Chatzimavroudis G; Katsinelos P
    World J Gastroenterol; 2014 Jul; 20(27):8867-85. PubMed ID: 25083060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective management of irritable bowel syndrome--the Manchester Model.
    Whorwell PJ
    Int J Clin Exp Hypn; 2006 Jan; 54(1):21-6. PubMed ID: 16316881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the management of irritable bowel syndrome.
    Cash BD; Chey WD
    Curr Gastroenterol Rep; 2003 Dec; 5(6):468-75. PubMed ID: 14602054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the Rome IV Criteria to Help Manage the Complex IBS Patient.
    Lin LD; Chang L
    Am J Gastroenterol; 2018 Apr; 113(4):453-456. PubMed ID: 29257142
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of tianeptine on melatonin homeostasis and psychosomatic symptoms in patients with irritable bowel syndrome.
    Chojnacki C; Walecka-Kapica E; Mokwinska M; Romanowski M; Pawlowicz M; Chojnacki J; Klupinska G
    J Physiol Pharmacol; 2013 Apr; 64(2):177-83. PubMed ID: 23756392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome.
    Nee J; Zakari M; Lembo AJ
    Expert Opin Pharmacother; 2015; 16(18):2781-92. PubMed ID: 26558923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritable bowel syndrome: a primer on management.
    Lacy BE
    Rev Gastroenterol Disord; 2003; 3 Suppl 3():S32-42. PubMed ID: 14502115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the functional net value of pharmacologic agents in treating irritable bowel syndrome.
    Shah E; Pimentel M
    Aliment Pharmacol Ther; 2014 May; 39(9):973-83. PubMed ID: 24612075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.